المؤلفون: J C, Alers, P J, Krijtenburg, A N, Vis, R F, Hoedemaeker, M F, Wildhagen, W C, Hop, T T, van Der Kwast, F H, Schröder, H J, Tanke, H, van Dekken

المصدر: The American journal of pathology. 158(2)

مصطلحات موضوعية: Chromosome Aberrations, Male, Short Communication, Statistics as Topic, Nucleic Acid Hybridization, Prostatic Neoplasms, DNA, Neoplasm, Adenocarcinoma, Middle Aged, Prostate-Specific Antigen, Cytogenetic Analysis, Humans, Mass Screening, Aged, Neoplasm Staging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::470e233f66bb29b35c7d8ca3480dc1a8
https://pubmed.ncbi.nlm.nih.gov/11159178

المؤلفون: Finelli A; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Antonio.finelli@uhn.ca., Komisarenko M; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Martin LJ; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Timilshina N; Division of Urology, Department of Surgical Oncology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, ON, Canada., Jain K; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Morris J; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Zlotta A; Division of Urology, Department of Surgical Oncology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, ON, Canada., Kulkarni G; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Perlis N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., van der Kwast T; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Evans A; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Ghai S; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Fleshner N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Alibhai SMH; Department of Medicine, Institute of Health Policy, Management, and Evaluation, University Health Network, University of Toronto, Toronto, ON, Canada., Hamilton RJ; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

المصدر: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Mar; Vol. 24 (1), pp. 69-76. Date of Electronic Publication: 2020 Mar 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Staging*, 5-alpha Reductase Inhibitors/*therapeutic use , Prostate/*pathology , Prostatic Neoplasms/*drug therapy , Watchful Waiting/*methods, Aged ; Biomarkers, Tumor/blood ; Biopsy ; Disease Progression ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome

المؤلفون: Deniffel D, Salinas E, Ientilucci M, Evans AJ, Fleshner N, Ghai S, Hamilton R, Roberts A, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA, Perlis N

المصدر: The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 1066-1067. Date of Electronic Publication: 2020 Jul 23.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Multiparametric Magnetic Resonance Imaging* , Prostatic Neoplasms*, Humans ; Male ; Neoplasm Grading

المؤلفون: Compérat E; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France. eva.comperat@aphp.fr., Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Brimo F; McGill University Health Center, Glen Site, Office E4-4188, 1001 Decarie Blvd, Montréal, QC, H4A 3J1, Canada., Delahunt B; Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand., Koch M; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA., Lopez-Beltran A; Department of Pathology, Champalimaud Clinical Center, Lisbon, Portugal., Reuter V; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Samaratunga H; Aquesta Specialized Uropathology, Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.; Princess Alexandra Hospital, Brisbane, QLD, Australia., Shanks JH; Department of Histopathology, The Christie NHS Foundation Trust, Manchester, UK., Tsuzuki T; Department of Pathology, Aichi Medical University, Aichi, Japan., van der Kwast T; Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada., Varma M; Department of Pathology, University Hospital of Wales, Cardiff, UK., Webster F; International Collaboration on Cancer Reporting, Sydney, NSW, Australia., Grignon D; Department of Pathology and Laboratory Medicine, IUH Pathology Laboratory, Indiana University School of Medicine, Indianapolis, IN, USA.

المصدر: Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Apr; Vol. 476 (4), pp. 521-534. Date of Electronic Publication: 2020 Jan 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma/*pathology , Pathology, Clinical/*standards , Prostate/*pathology , Urinary Bladder/*pathology, Carcinoma/diagnosis ; Humans ; Male ; Pathologists ; Research Report

المؤلفون: Varma M; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK. wptmv@cf.ac.uk., Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Brimo F; Department of Pathology, McGill University Health Center, Montréal, QC, Canada., Compérat E; Department of Pathology, Hopital Tenon, HUEP, Sorbonne University, Paris, France., Delahunt B; Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand., Koch M; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA., Lopez-Beltran A; Department of Pathology, Champalimaud Clinical Center, Lisbon, Portugal., Reuter V; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Samaratunga H; Aquesta Specialized Uropathology, Brisbane, QLD, Australia.; The University of Queensland, Centre for Clinical Research, Brisbane, QLD, Australia.; Princess Alexandra Hospital, Brisbane, QLD, Australia., Shanks JH; Department of Histopathology, The Christie NHS Foundation Trust, Manchester, UK., Tsuzuki T; Department of Pathology, Aichi Medical University, Aichi, Japan., van der Kwast T; Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada., Webster F; International Collaboration on Cancer Reporting, Sydney, NSW, Australia., Grignon D; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, IUH Pathology Laboratory, Indianapolis, IN, USA.

المصدر: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2020 Apr; Vol. 33 (4), pp. 700-712. Date of Electronic Publication: 2019 Nov 04.

نوع المنشور: Dataset; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Biopsy/*standards , Carcinoma/*pathology , Pathology/*standards , Urologic Neoplasms/*pathology, Carcinoma/surgery ; Consensus ; Data Accuracy ; Humans ; Neoplasm Invasiveness ; Neoplasm Staging ; Predictive Value of Tests ; Urologic Neoplasms/surgery

المؤلفون: Horwich A; Emeritus Professor, The Institute of Cancer Research, London, UK; Emeritus Professor, The Institute of Cancer Research, London, UK. Electronic address: clinicalguidelines@esmo.org., Babjuk M; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria., Bellmunt J; IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Harvard Medical School, Boston, USA., Bruins HM; Department of Urology, Radboud University Medical Center, Nijmegen., De Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., De Santis M; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Charité University Hospital, Berlin, Germany., Gillessen S; Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK; Division of Oncology and Haematology, Kantonsspital St Gallen, St Gallen; University of Bern, Bern, Switzerland., James N; University Hospitals Birmingham NHS Foundation Trust, Birmingham; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham., Maclennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Powles T; The Royal Free NHS Trust, London; Barts Cancer Institute, Queen Mary University of London, London, UK., Ribal MJ; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain., Shariat SF; Depatment of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York; Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Van Der Kwast T; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique Hôpitaux de Paris, Paris; Paris Descartes University, Paris, France., Agarwal N; Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, USA., Arends T; Urology Department, Canisius-Wilhelmina Ziekenhuis Nijmegen, Nijmegen, The Netherlands., Bamias A; 2nd Propaedeutic Dept of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece., Birtle A; Division of Cancer Sciences, University of Manchester, Manchester; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK., Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Bochner BH; Department of Urology, Weill Cornell Medical College, New York; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA., Bolla M; Emeritus Professor of Radiation Oncology, Grenoble - Alpes University, Grenoble, France., Boormans JL; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Bossi A; Department of Radiation Oncology, Gustave Roussy Institute, Villejuif, France., Briganti A; Department of Urology, Urological Research Institute, Milan; Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy., Brummelhuis I; Department of Urology, Radboud University Medical Center, Nijmegen., Burger M; Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Castellano D; Medical Oncology Department, 12 de Octubre University Hospital (CIBERONC), Madrid, Spain., Cathomas R; Department Innere Medizin, Abteilung Onkologie und Hämatologie, Kantonsspital Graubünden, Chur, Switzerland., Chiti A; Department of Biomedical Sciences, Humanitas University, Milan; Humanitas Research Hospital, Milan, Italy., Choudhury A; Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK., Compérat E; Department of Pathology, Tenon Hospital, HUEP, Paris; Sorbonne University, Paris, France., Crabb S; Cancer Sciences Unit, University of Southampton, Southampton, UK., Culine S; Department of Cancer Medicine, Hôpital Saint Louis, Paris., De Bari B; Radiation Oncology Department, Centre Hospitalier Régional Universitaire 'Jean Minjoz' of Besançon, INSERM UMR 1098, Besançon, France; Radiation Oncology Department, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Switzerland., DeBlok W; Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands., De Visschere PJL; Department of Radiology and Nuclear Medicine, Division of Genitourinary Radiology and Mammography, Ghent University Hospital, Ghent., Decaestecker K; Department of Urology, Ghent University Hospital, Ghent, Belgium., Dimitropoulos K; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Dominguez-Escrig JL; Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Fanti S; Department of Nuclear Medicine, Policlinico S Orsola, University of Bologna, Bologna, Italy., Fonteyne V; Department of Radiotherapy Oncology, Ghent University Hospital, Ghent, Belgium., Frydenberg M; Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia., Futterer JJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Gakis G; Department of Urology and Paediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany., Geavlete B; Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania., Gontero P; Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy., Grubmüller B; Department of Urology, Medical University of Vienna, Vienna, Austria., Hafeez S; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK., Hansel DE; Department of Urology, University of California, San Diego Pathology, La Jolla, USA., Hartmann A; Institute of Pathology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany., Hayne D; Department of Urology, UWA Medical School, University of Western Australia, Perth, Australia., Henry AM; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Hernandez V; Department of Urology, Hospital Universitario Fundación de Alcorcón, Madrid, Spain., Herr H; Urology Service, Department of Urology, Memorial Sloan Kettering Cancer Center, New York, USA., Herrmann K; Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany., Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK; Mount Vernon Centre for Cancer Treatment, London, UK., Huguet J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy., Jones R; Institute of Cancer Sciences, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Kamat AM; Department of Urology - Division of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, USA., Khoo V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London; Department of Clinical Oncology, The Royal Marsden NHS Foundation Trust, London, UK; Department of Medicine, University of Melbourne, Melbourne; Monash University, Melbourne, Australia., Kiltie AE; CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK., Krege S; Department of Urology, Pediatric Urology and Urologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Ladoire S; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Lara PC; Department of Oncology, Hospital Universitario San Roque, Canarias; Universidad Fernando Pessoa, Canarias, Spain., Leliveld A; Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Linares-Espinós E; Department of Urology, University Hospital La Paz, Madrid, Spain., Løgager V; Department of Radiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Loriot Y; Département de Médecine Oncologique, Gustave Roussy, INSERM U981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France., Meijer R; UMC Utrecht Cancer Center, MS Oncologic Urology, Utrecht, The Netherlands., Carmen Mir M; Servicio de Urología, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Moschini M; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland., Mostafid H; Department of Urology, Royal Surrey County Hospital, Guildford, UK., Müller AC; Department of Radiation Oncology, Eberhard Karls University, Tübingen, Germany., Müller CR; Cancer Treatment Centre, Sorlandet Hospital, Kristiansand, Norway., N'Dow J; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK., Necchi A; Department of Medical Oncology, Istituto Nazionale Tumori of Milan, Milan, Italy., Neuzillet Y; Department of Urology, Hospital Foch, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France., Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Oldenburg J; Department of Oncology, Akershus University Hospital, Lørenskog; Faculty of Medicine, University of Oslo, Oslo, Norway., Osanto S; Department of Clinical Oncology, Leiden University Medical Center, Leiden., Oyen WJG; Department of Biomedical Sciences, Humanitas University, Milan; Humanitas Research Hospital, Milan, Italy; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands., Pacheco-Figueiredo L; Department of Urology, Centro Hospitalar São João, Porto; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal., Pappot H; Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Patel MI; Department of Urology, Westmead Hospital, University of Sydney, Sydney, Australia., Pieters BR; Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam., Plass K; EAU Guidelines Office, Arnhem, The Netherlands., Remzi M; Department of Urology, Medical University of Vienna, Vienna, Austria., Retz M; Department of Urology, Rechts der Isar Medical Center, Technical University of Munich, Munich, Germany., Richenberg J; Department of Imaging and Nuclear Medicine, Royal Sussex County Hospital, Brighton; Brighton and Sussex Medical School, Brighton, UK., Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg., Roghmann F; Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany., Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York, USA., Rouprêt M; Department of Urology, Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris., Rouvière O; Hospices Civils de Lyon, Service d'Imagerie Urinaire et Vasculaire, Hôpital Edouard Herriot, Lyon; Université de Lyon, Université Lyon 1, Faculté de Médecine Lyon Est, Lyon, France., Salembier C; Department of Radiation Oncology, Europe Hospitals Brussels, Brussels, Belgium., Salminen A; Department of Urology, University Hospital of Turku, Turku, Finland., Sargos P; Department of Radiotherapy, Institut Bergonié, Bordeaux, France., Sengupta S; Department of Surgery, Austin Health, University of Melbourne, Melbourne; Eastern Health Clinical School, Monash University, Melbourne, Australia., Sherif A; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden., Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Smits A; Department of Urology, Radboud University Medical Center, Nijmegen., Stenzl A; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany., Thalmann GN; Department of Urology, Inselspital, Bern University Hospital, Berne, Switzerland., Tombal B; Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCL, Brussels, Belgium., Turkbey B; Molecular Imaging Program, National Cancer Institute, Bethesda, USA., Vahr Lauridsen S; Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Van Der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen., Van Poppel H; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Vartolomei MD; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Cell and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures, Romania., Veskimäe E; Department of Urology, Tampere University Hospital, Tampere, Finland., Vilaseca A; Uro-Oncology Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain., Vives Rivera FA; Clinica HematoOncologica Bonadona Prevenir, Universidad Metropolitana, Clinica Club de Leones, Barranquilla, Colombia., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany., Wiklund P; Icahn School of Medicine, Mount Sinai Health System, New York City, USA; Department of Urology, Karolinska Institutet, Stockholm, Sweden., Williams A; Department of Urology, Auckland City Hospital, Auckland, New Zealand., Zigeuner R; Department of Urology, Medizinische Universität Graz, Graz, Austria., Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Nov 01; Vol. 30 (11), pp. 1697-1727.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Consensus* , Practice Guidelines as Topic*, Medical Oncology/*standards , Urinary Bladder Neoplasms/*therapy , Urology/*standards, Delphi Technique ; Europe ; Humans ; International Cooperation ; Medical Oncology/methods ; Neoplasm Staging ; Societies, Medical/standards ; Stakeholder Participation ; Surveys and Questionnaires ; Urinary Bladder/pathology ; Urinary Bladder Neoplasms/pathology ; Urology/methods

المؤلفون: Kweldam CF; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands., van Leenders GJ; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands., van der Kwast T; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.

المصدر: Histopathology [Histopathology] 2019 Jan; Vol. 74 (1), pp. 146-160.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Grading/*methods , Prostatic Neoplasms/*pathology, Humans ; Male

المؤلفون: Van der Kwast T; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.

المصدر: The Journal of urology [J Urol] 2016 Aug; Vol. 196 (2), pp. 303-4. Date of Electronic Publication: 2016 May 14.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Grading* , Prostatectomy*, Humans ; Prostatic Neoplasms/surgery

المؤلفون: Islam SS; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Urology, The Hospital for Sick Children, Toronto, ON, Canada., Mokhtari RB; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada., Noman AS; Department of Biochemistry and Molecular Biology, University of Chittagong, Chittagong, Bangladesh., Uddin M; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Rahman MZ; Department of Pathology, Chittagong Medical College, Chittagong, Bangladesh., Azadi MA; Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh., Zlotta A; Department of Uro-Oncology, Mount Sinai Hospital, Toronto, ON, Canada., van der Kwast T; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Yeger H; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada., Farhat WA; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Urology, The Hospital for Sick Children, Toronto, ON, Canada.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2016 May; Vol. 55 (5), pp. 537-51. Date of Electronic Publication: 2015 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: Epithelial-Mesenchymal Transition*/drug effects, Hedgehog Proteins/*metabolism , Neoplastic Stem Cells/*drug effects , Transforming Growth Factor beta1/*pharmacology , Urinary Bladder Neoplasms/*pathology, Animals ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Cell Movement ; Female ; Gene Expression Regulation, Neoplastic ; Hedgehog Proteins/genetics ; Humans ; Mice ; Neoplasm Grading ; Neoplasm Staging ; Neoplasm Transplantation ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Signal Transduction/drug effects ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/metabolism

المؤلفون: Hussein S; Department of Laboratory Medicine, Kuwait Cancer Control Center, Kuwait, Kuwait., Satturwar S; Department of Pathology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Van der Kwast T; Department of Pathology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

المصدر: Journal of clinical pathology [J Clin Pathol] 2015 Jul; Vol. 68 (7), pp. 511-5. Date of Electronic Publication: 2015 Apr 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/ethnology , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/pathology, Adult ; Age of Onset ; BRCA2 Protein/genetics ; Biomarkers, Tumor/genetics ; Genetic Predisposition to Disease ; Heredity ; Homeodomain Proteins/genetics ; Humans ; Male ; Middle Aged ; Mutation ; Neoplasm Grading ; Phenotype ; Prevalence ; Risk Factors